TY - JOUR
T1 - Reworsening of Recurrent Guillain-Barré Syndrome Triggered by COVID-19 Infection
AU - Vita, Gian Luca
AU - Terranova, Carmen
AU - Sframeli, Maria
AU - Toscano, Antonio
AU - Vita, Giuseppe
PY - 2021
Y1 - 2021
N2 - Introduction: Guillain-Barré Syndrome (GBS) is an acute, immune-mediated, generalized polyradiculoneuropathy often triggered by a bacterial or viral infection, vaccination, or surgery. During the SARS-CoV-2 pandemic, some patients were reported with GBS associated COVID-19 infection. Case Presentation: We report, herein, a patient who had a recurrent GBS after forty years. Intravenous immunoglobulins (IVIg) induced improvement, but her condition worsened suddenly after twenty days, coinciding with a COVID-19 infection. A second IVIg cycle was administered, and she improved again. Conclusion: The take-home message is that in the current pandemic, any re-worsening or lack of improvement after appropriate treatment of GBS or possibly other autoimmune neurological diseases must be checked to determine if it is related to COVID-19 infection.
AB - Introduction: Guillain-Barré Syndrome (GBS) is an acute, immune-mediated, generalized polyradiculoneuropathy often triggered by a bacterial or viral infection, vaccination, or surgery. During the SARS-CoV-2 pandemic, some patients were reported with GBS associated COVID-19 infection. Case Presentation: We report, herein, a patient who had a recurrent GBS after forty years. Intravenous immunoglobulins (IVIg) induced improvement, but her condition worsened suddenly after twenty days, coinciding with a COVID-19 infection. A second IVIg cycle was administered, and she improved again. Conclusion: The take-home message is that in the current pandemic, any re-worsening or lack of improvement after appropriate treatment of GBS or possibly other autoimmune neurological diseases must be checked to determine if it is related to COVID-19 infection.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85122181677&origin=inward
U2 - 10.2174/1874205X02115010048
DO - 10.2174/1874205X02115010048
M3 - Article
SN - 1874-205X
VL - 15
SP - 48
EP - 51
JO - Open Neurology Journal
JF - Open Neurology Journal
IS - 1
ER -